Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27629796 | 0.88 | MEN1 (0.41) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL28003009 | 0.86 | MEN1 (0.42) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL28040132 | 0.85 | P2RX7 (0.40) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL27825548 | 0.83 | CYP2C19 (0.40) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL21084631 | 0.83 | CYP2C19 (0.40) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL44530 | 0.82 | CYP2C19 (0.42) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL6713174 | 0.81 | CYP2C19 (0.41) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL28476699 | 0.80 | CYP2C19 (0.41) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL27709155 | 0.80 | P2RX7 (0.41) | MEN1KMT2AALDH1A1LMNAMAPT | |
| SCHEMBL27494027 | 0.79 | CYP2C19 (0.38) | MEN1KMT2AALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105456159-A | Chitosan sunscreen cream and preparation method thereof | RAO YAQIN | 2016-04-06 | — | — | CN | claimed |
| CN-105456158-A | Amaranthus mangostanus sunscreen cream and preparation method thereof | RAO YAQIN | 2016-04-06 | — | — | CN | claimed |
| CN-105380888-A | Radix Scutellariae sunscreen cream and preparation method thereof | RAO YAQIN | 2016-03-09 | — | — | CN | claimed |
| CN-105362193-A | Sunscreen cream and preparation method thereof | RAO YAQIN | 2016-03-02 | — | — | CN | claimed |
| CN-105342972-A | Wild chrysanthemum sun cream and preparation method thereof | RAO YAQIN | 2016-02-24 | — | — | CN | claimed |
| CN-105342973-A | Tea polyphenol sun cream and preparation method thereof | RAO YAQIN | 2016-02-24 | — | — | CN | claimed |
| CN-105342970-A | Mint leaf sun cream and preparation method thereof | RAO YAQIN | 2016-02-24 | — | — | CN | claimed |
| CN-105342971-A | Glycerinum sun cream and preparing method thereof | RAO YAQIN | 2016-02-24 | — | — | CN | claimed |
| CN-1295832-A | Cosmetics Compositions having at least one kind of siloxanes/ester acrylate and at least one kind of photo protective agent | OREAL (FR) | 2001-05-23 | — | — | CN | claimed |
| US-11510860-B2 | Composition comprising a UV-screening agent, an acrylic polymer and a fatty acid ester of dextrin | L'OREAL (FR) | 2022-11-29 | — | — | US | disclosed |
| US-20200315944-A1 | COMPOSITION COMPRISING A UV-SCREENING AGENT, AN ACRYLIC POLYMER AND A FATTY ACID ESTER OF DEXTRIN | L'OREAL (FR) | 2020-10-08 | — | — | US | disclosed |
| CN-107349113-B | Sun-screening agent microsphere completely wrapped by silicon and preparation method thereof | 广州玮弘祺生物科技有限公司 | 2020-04-14 | — | — | CN | disclosed |
| CN-109320138-A | A kind of modified asphalt mixture and preparation method thereof that anti-time property is good | 湖北津泰环保科技有限公司 | 2019-02-12 | — | — | CN | disclosed |
| CN-109294257-A | A kind of high-weatherability modified pitch and preparation method thereof | 湖北津泰环保科技有限公司 | 2019-02-01 | — | — | CN | disclosed |
| CN-1316977-C | Stable brivudine topical formulations | MENARINI RICERCHE SPA (IT) | 2007-05-23 | — | — | CN | disclosed |
| CN-1246303-C | Indanylidene compounds | THIMRASS KG (DE) | 2006-03-22 | — | — | CN | disclosed |
| CN-1604782-A | Stabilized brivudine topical formulations | MENARINI RICERCHE SPA (IT) | 2005-04-06 | — | — | CN | disclosed |
| CN-1184475-C | External test method for water-resisting effect of sunshine-resistant products | SHANGHAI JIAHUA UNION CO LTD (CN) | 2005-01-12 | — | — | CN | disclosed |
| CN-1385699-A | External test method for water-resisting effect of sunshine-resistant products | SHANGHAI JIAHUA UNION CO LTD (CN) | 2002-12-18 | — | — | CN | disclosed |
| CN-1218806-A | Sorbic acid vitamin C ester | BASF AG (DE) | 1999-06-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11510860-B2 | Composition comprising a UV-screening agent, an acrylic polymer and a fatty acid ester of dextrin | ALAD, USP14, CUTA | MEN1 3321/4885KMT2A 4277/4885ALDH1A1 165/4885 |
| US-20200315944-A1 | COMPOSITION COMPRISING A UV-SCREENING AGENT, AN ACRYLIC POLYMER AND A FATTY ACID ESTER OF DEXTRIN | ALAD, USP14, CUTA | MEN1 3321/4885KMT2A 4277/4885ALDH1A1 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.